(19)
(11) EP 1 551 803 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
13.12.2006 Bulletin 2006/50

(45) Mention of the grant of the patent:
11.10.2006 Bulletin 2006/41

(21) Application number: 03762827.8

(22) Date of filing: 11.04.2003
(51) International Patent Classification (IPC): 
C07D 209/52(2006.01)
C07D 417/12(2006.01)
C07D 401/12(2006.01)
A61K 31/403(2006.01)
 C07D 403/12(2006.01)
C07D 413/12(2006.01)
C07D 407/12(2006.01)
(86) International application number:
PCT/IB2003/001367
(87) International publication number:
WO 2004/005252 (15.01.2004 Gazette 2004/03)

(54)

AZABICYCLO DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS

AZABICYCLODERIVATE ALS ANTAGONISTEN DES MUSCARINISCHEN REZEPTORS

DERIVES AZABICYCLO UTILISES COMME ANTAGONISTES DES RECEPTEUR MUSCARINIQUES

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 08.07.2002 WO PCT/IB02/02663

(43) Date of publication of application:
13.07.2005 Bulletin 2005/28

(73) Proprietor: Ranbaxy Laboratories Limited
Gurgaon - 122001, Haryana (IN)

(72) Inventors:
  • SALMAN, Mohammad
    122001 Gurgaon, Haryana (IN)
  • MEHTA, Anita
    Buffalo Grove, IL 60089 (US)
  • SARMA, Pakala, Kumara, Savithru
    12201 Gurgaon, Haryana (IN)
  • SHETTY, Shankar, Jayram
    122001 Gurgaon, Haryana (IN)
  • DHARMARAJAN, Sankaranarayanan
    122001 Gurgaon, Haryana (IN)
  • KUMAR, Naresh
    122017 Gurgaon, Haryana (IN)
  • SILAMKOTI, Arundutt, Viswanatham
    500 010 Bolarium, Secunderabad (IN)
  • CHUGH, Anita
    110012 New Delhi, Delhi (IN)

(74) Representative: Cronin, Brian Harold John et al
CRONIN Intellectual Property Route de Clémenty 62
1260 Nyon
1260 Nyon (CH)


(56) References cited: : 
EP-A- 0 863 141
WO-A-02/051841
 WO-A-02/04402
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).